Analysts Set Calyxt, Inc. (CLXT) Target Price at $29.05
Shares of Calyxt, Inc. (NASDAQ:CLXT) have been assigned an average recommendation of “Buy” from the six analysts that are presently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $29.05.
A number of brokerages have weighed in on CLXT. Zacks Investment Research upgraded shares of Calyxt from a “sell” rating to a “hold” rating in a report on Monday, January 8th. Ladenburg Thalmann Financial Services began coverage on shares of Calyxt in a report on Wednesday, December 20th. They issued a “buy” rating and a $34.25 price objective on the stock. Citigroup cut their price objective on shares of Calyxt from $27.00 to $22.00 and set a “neutral” rating on the stock in a report on Thursday, November 16th. Jefferies Group upped their price objective on shares of Calyxt to $27.00 and gave the stock a “buy” rating in a report on Wednesday, November 1st. Finally, BMO Capital Markets began coverage on shares of Calyxt in a report on Monday, October 30th. They issued an “outperform” rating and a $32.00 price objective on the stock.
Several large investors have recently bought and sold shares of CLXT. Bank of New York Mellon Corp purchased a new stake in shares of Calyxt during the third quarter valued at approximately $542,000. Schwab Charles Investment Management Inc. purchased a new stake in shares of Calyxt during the third quarter valued at approximately $358,000. California State Teachers Retirement System purchased a new stake in shares of Calyxt during the third quarter valued at approximately $323,000. Finally, American International Group Inc. purchased a new stake in shares of Calyxt during the third quarter valued at approximately $133,000. Hedge funds and other institutional investors own 21.13% of the company’s stock.
Calyxt (NASDAQ:CLXT) last announced its quarterly earnings data on Monday, November 13th. The company reported ($0.51) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.16) by ($0.35). Calyxt had a negative return on equity of 101.69% and a negative net margin of 5,969.52%. equities analysts predict that Calyxt will post -1.07 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/analysts-set-calyxt-inc-clxt-target-price-at-29-05/1811367.html.
Calyxt Company Profile
Calyxt, Inc is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.